| European Case Law Identifier: | ECLI:EP:BA:2013:J000613.20130723 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 23 July 2013 | ||||||||
| Case number: | J 0006/13 | ||||||||
| Application number: | 09729936.6 | ||||||||
| IPC class: | A61K 31/505 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Novel (pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases | ||||||||
| Applicant name: | Novelix Pharmaceuticals, Inc. | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.1.01 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Withdrawal File inspection Register Legal certainty |
||||||||
| Catchwords: |
In the interest of legal certainty for third parties, and taking into account the public function of the register, a third party upon file inspection must have had good reason to suspect that the withdrawal was made in error in order to allow a retraction thereof. |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/j130006eu1.html
Date retrieved: 17 May 2021